SCHEMBL6528279

SCHEMBL6528279

COc1ccc(Sc2nc(Nc3cccc(F)c3)nc(N(CCN3CCCCC3)C(=O)[C@@H](N)CC(C)C)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GALR2 O43603 3/20 0.38
HTR1A P08908 1/20 0.35
MC4R P32245 1/20 0.35
PDPK1 O15530 3/20 0.35
SRC P12931 3/20 0.34
LCK P06239 2/20 0.34
KDR P35968 2/20 0.34
MAPK14 Q16539 2/20 0.34
SYK P43405 2/20 0.34
TERT O14746 1/20 0.34
MMP3 P08254 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
LIMK1 P53667 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528784 0.99 GALR2 (0.37) GALR2HTR1AMC4RPDPK1SRC
SCHEMBL6529648 0.94 PDPK1 (0.41) PDPK1SRCMMP3HTR2AHTR2C
SCHEMBL6530216 0.88 NPC1 (0.38) GALR2
SCHEMBL6528181 0.87 TBK1 (0.35) SYKCYP1A2CYP2D6CYP2C19
SCHEMBL6528749 0.85 MEN1 (0.37) SYKCYP1A2CYP2D6CYP2C19
SCHEMBL6531461 0.84 EGFR (0.39) SYKCYP1A2CYP2D6CYP2C19
SCHEMBL6533478 0.83 ITK (0.36) SYK
SCHEMBL6529551 0.83 CHRNA7 (0.35) SYK
SCHEMBL6530876 0.82 MAPT (0.38)
SCHEMBL6531968 0.82 POLB (0.39) PDPK1SRCSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed